When does the CORONA Remedies Limited IPO open and close?

The CORONA Remedies Limited IPO opens for subscription on December 8, 2025 and closes on December 10, 2025. Shares are expected to list on December 15, 2025.

What is the issue price of the CORONA Remedies Limited IPO?

The CORONA Remedies Limited IPO was priced at ₹1,062 per equity share.

What is the lot size for the CORONA Remedies Limited IPO?

The lot size is 14 equity shares. At ₹1,062 per share, one lot requires ₹14,868.

What is the issue size of the CORONA Remedies Limited IPO?

The total issue size is ₹655.37 crore.

How did CORONA Remedies Limited perform on listing?

CORONA Remedies Limited opened at ₹1,470 against an issue price of ₹1,062, a premium of 38.42% on debut.

CORONA Remedies Limited IPO — Dates, Price Band, Lot Size, Financials & Prospectus Analysis | Anvest

Listed on ExchangeMAINBOARDCORONA Official SEBI Filing

CORONA Remedies Limited

Issue Price

₹1062

Total Issue Size

₹655.37 Cr

Listing Date

15 Dec – 15 Dec 2025

Market Lot

14 Shares

Listing Price

₹1470

Listing Debut

+38.42%

Issue Timeline & Lifecycle

RHP Filed

3 Dec 2025

Issue Opens

8 Dec 2025

Issue Closes

10 Dec 2025

Allotment

11 Dec 2025

Indicative, per filing

Exchange Debut

15 Dec 2025

RHP Filed

3 Dec 2025

Issue Opens

8 Dec 2025

Issue Closes

10 Dec 2025

Allotment

11 Dec 2025 · indicative

Exchange Debut

15 Dec 2025

Subscription Demand

Day 3 Closed

Updated:10 Dec, 7:00 pm·NSE

137.04x Fully Subscribed

62.65 Cr shares bid on 45.72 L total issue

Momentum

Day 3137.04xLatest

Qualified Institutional (QIB)

278.52x50% Quota

Non-Institutional / HNI

208.88x15% Quota

Retail Individual (RII)

28.73x35% Quota

Employee Reservation

14.72xReserved

Qualified Institutional (QIB)50% Quota

278.52x

Non-Institutional / HNI15% Quota

208.88x

Retail Individual (RII)35% Quota

28.73x

Employee ReservationReserved

14.72x

Fundamentals & Key Metrics

Period:FY25

Valuation & Multiples

5 items

Implied Market Capℹ

₹6,495 Cr

P/E Ratioℹ

43.47x

P/B Ratioℹ

10.71x

Price to Salesℹ

5.43x

EV/EBITDAℹ

14.41x

Profitability & Returns

6 items

EBITDA Marginℹ

38.03%

Profit Marginℹ

12.49%

RoNWℹ

24.65%

ROCEℹ

31.26%

Basic EPSℹ

₹24.43

Book Valueℹ

₹99.14

Financial Health & Solvency

4 items

Debt/Equityℹ

0.10x

Net Worthℹ

₹606.34 Cr

Total Debtℹ

₹62.7 Cr

Operating Cash Flowℹ

₹190.5 Cr

Financials at a glance

Consolidated

Statement: Income StatementPeriod: Restated Multi-Year (FY)

Shareholding, Ownership & Dilution

7 disclosed holders

Pre-Offer Shareholding Distribution

Breakdown of major disclosed shareholders prior to the issue

100.00% Pre-Issue

100%Pre-Offer

Sepia Investments Limited

25.99%

Niravkumar Kirtikumar Mehta

22.00%

Ankur KirtiKumar Mehta

22.00%

Dr. Kirtikumar Laxmidas Mehta

22.00%

Minaxi Kirtikumar Mehta

2.18%

Others

5.83%

Ownership Impact of the IPO

What is newly issued, what changes hands, and what stays put

100.00% Post-Issue

100%POST-OFFER

Pre-IPO Retained

89.91%

Fresh-Issue Dilution

0.00%

OFS Changes Hands₹655.37 Cr · 100.0% of offer

10.09%

Total Company Offered in IPO10.09%

Calculated from share counts disclosed in the offer filing.

Disclosed Pre-Offer Shareholders Table

AI Summary

Filing-backed

Prospectus Research

Analyze business model, competitive strengths, use of issue proceeds, and disclosed risk factors with official page citations.

Issue intermediaries

Lead book managers

JM Financial Limited, IIFL Capital Services Limited, Kotak Mahindra Capital Company Limited

Registrar to the issue

Bigshare Services Private Limited

Listing venues

NSE,BSE

Listed Peer Valuation & Returns

Industry Avg P/E:43.74x

Swipe left / right to view all valuation metrics→

Company
CORONA Remedies LimitedThis Issue	—	₹1.20K Cr	₹24.43	₹99.14	24.65%
Sanofi India Limited	24.47x	₹2.01K Cr	₹179.46	₹373.68	48.05%
Pfizer Limited	29.63x	₹2.28K Cr	₹167.79	₹921.88	18.20%
Alkem Laboratories Limited	31.39x	₹12.96K Cr	₹181.11	₹1002.37	18.07%
J.B. Chemicals & Pharmaceuticals Limited	42.60x	₹3.92K Cr	₹41.56	₹220.88	19.21%
Abbott India Limited	45.17x	₹6.41K Cr	₹665.62	₹1992.14	33.41%
Mankind Pharma Limited	45.77x	₹12.21K Cr	₹49.20	₹352.51	13.89%
GlaxoSmithKline Pharmaceuticals Limited	46.87x	₹3.75K Cr	₹54.76	₹115.19	47.54%
Eris Lifesciences Limited	61.81x	₹2.89K Cr	₹25.81	₹209.73	12.21%
Torrent Pharmaceuticals Limited	65.91x	₹11.52K Cr	₹56.47	₹224.28	25.18%